Edition:
United States

OncoMed Pharmaceuticals Inc (OMED.OQ)

OMED.OQ on NASDAQ Stock Exchange Global Select Market

3.68USD
26 May 2017
Change (% chg)

$0.16 (+4.55%)
Prev Close
$3.52
Open
$3.57
Day's High
$3.73
Day's Low
$3.53
Volume
93,459
Avg. Vol
106,167
52-wk High
$15.30
52-wk Low
$3.25

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -0.44 December 27 May 2017

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 2 2 2 2
(2) OUTPERFORM 1 1 6 6
(3) HOLD 5 5 1 1
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 2.38 2.38 1.89 1.89

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Jun-17 8 4.85 6.30 0.00 --
Quarter Ending Sep-17 8 8.14 25.00 3.50 --
Year Ending Dec-17 8 23.67 26.40 16.56 82.82
Year Ending Dec-18 8 40.47 114.73 19.40 100.47
Earnings (per share)
Quarter Ending Jun-17 7 -0.44 0.11 -0.68 --
Quarter Ending Sep-17 7 -0.40 0.19 -0.71 --
Year Ending Dec-17 7 -1.71 -0.61 -2.79 -2.11
Year Ending Dec-18 7 -1.58 0.03 -2.47 -1.86

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Mar-17 6.97 6.21 0.76 10.85
Quarter Ending Dec-16 8.89 6.22 2.67 30.01
Quarter Ending Sep-16 9.48 5.92 3.56 37.57
Quarter Ending Jun-16 8.09 6.66 1.43 17.62
Quarter Ending Mar-16 8.28 6.35 1.93 23.29

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Jun-17 4.85 4.85 10.58 34.11 --
Quarter Ending Sep-17 8.14 8.14 10.77 27.99 --
Year Ending Dec-17 23.67 23.67 43.38 95.07 82.82
Year Ending Dec-18 40.47 40.47 52.66 60.95 100.47

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Jun-17 0 0 0 3
Quarter Ending Sep-17 0 0 0 3
Year Ending Dec-17 0 0 2 3
Year Ending Dec-18 0 0 2 3
Earnings

More From Around the Web